Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2012 Nov;194(22):6339–6340. doi: 10.1128/JB.01462-12

Complete Genome Sequence of Mycobacterium vaccae Type Strain ATCC 25954

Yung S Ho a, Sabir A Adroub a, Maram Abadi a, Bader Al Alwan a, Reham Alkhateeb a, Ge Gao a, Alaa Ragab a, Shahjahan Ali b, Dick van Soolingen c,d, Wilbert Bitter e, Arnab Pain a, Abdallah M Abdallah a,
PMCID: PMC3486380  PMID: 23105074

Abstract

Mycobacterium vaccae is a rapidly growing, nontuberculous Mycobacterium species that is generally not considered a human pathogen and is of major pharmaceutical interest as an immunotherapeutic agent. We report here the annotated genome sequence of the M. vaccae type strain, ATCC 25954.

GENOME ANNOUNCEMENT

There is an increasing interest in the role of nontuberculous mycobacteria (NTM) as pathogens causing pulmonary disease and disseminated disease in both immunocompetent and immunocompromised individuals. NTM species previously considered nonpathogenic have now been shown to cause disease in humans. Mycobacterium vaccae, a rapidly growing and yellow-pigmented NTM, was first isolated, described, and named in 1962 (4). This bacterium can be isolated from the environment, including soil and water and especially in contact with cattle, as well as from bovine lactic ducts, skin nodules, and milk products (13). Because of the strong association of this Mycobacterium species with cattle, it was named M. vaccae, as vaccae is the Latin word for cow. M. vaccae, previously considered nonpathogenic, has been associated rarely with pulmonary infections and soft tissue infections (5). However, M. vaccae is mainly being studied for use as an immunotherapeutic agent together with chemotherapy in the treatment of tuberculosis and other diseases, such as cancer, asthma, atopic dermatitis, and psoriasis (2, 6, 7, 9, 10). To better understand the molecular basis of M. vaccae and further study phylogenetic relationships and the genetic factors responsible for pathogenicity, we determined the complete genome sequence of this microorganism. Whole-genome sequencing is also important to facilitate a more reliable genetic identification between and within Mycobacterium species.

The whole-genome sequencing of the M. vaccae type strain, ATCC 25954, was performed on the Illumina HiSeq2000 platform using a 100-bp paired-end library with an insert size of 500 bp. A total of 24.7 million Illumina sequencing reads were generated. These short sequence reads were quality trimmed before being de novo assembled using velvet (14). The genome was further improved with ICORN (8) and IMAGE (12) as described in PAGIT (11) before it was scaffolded with SSPACE (3). The final assembly has 33 supercontigs and an N50 of 383,962 bp. The genome annotation was performed using the NCBI Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP).

The M. vaccae type strain ATCC 25954 genome sequence is 6,245,372 bp in length, with 5,949 predicted coding sequences. The overall GC content of the chromosome amounted to 68.5%. There are 49 tRNA-encoding genes and six sets of rRNA operons as predicted by the PGAAP pipeline. It was possible to assign a biological function to 71% (4,220) of the coding sequences on the M. vaccae chromosome.

The automated annotation of this genome by the RAST server (1) revealed that M. vaccae is most closely related to Mycobacterium vanbaalenii PYR-1, compared to all mycobacteria with complete genome sequences currently available. Furthermore, RAST annotation revealed that this genome may contain many genes encoding proteins that are categorized in the subsystem category of amino acids and derivatives (583 genes), followed by cofactors, vitamins, prosthetic groups, and pigments (371 genes). There are 57 genes encoding products that may be involved in virulence, disease, and defense, of which 37 are linked with resistance to antibiotics and toxic compounds, 12 are involved in invasion and intracellular resistance, and 8 are linked with antimicrobial products, such as bacteriocins.

Nucleotide sequence accession numbers.

This Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number ALQA00000000. The version described in this paper is the first version, ALQA00000000.

ACKNOWLEDGMENT

This work was supported by faculty funding to A.P. by King Abdullah University of Science and Technology.

We thank the Dutch National Institute for Public Health and the Environment (RIVM) for providing the strain. We gratefully acknowledge the support of Roy Ummels at the Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, and Tridia van der Laan from the RIVM, Bilthoven, the Netherlands.

REFERENCES

  • 1. Aziz RK, et al. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9:75 doi:10.1186/1471-2164-9-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Balagon MV, et al. 2000. Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae. Int. J. Dermatol. 39:51–58 [DOI] [PubMed] [Google Scholar]
  • 3. Boetzer M, Henkel CV, Jansen HJ, Butler D, Pirovano W. 2011. Scaffolding pre-assembled contigs using SSPACE. Bioinformatics 27:578–579 [DOI] [PubMed] [Google Scholar]
  • 4. Boenickse R, Juhasz SE. 1964. Beschreibung der neuen Species Mycobacterium vaccae no. sp. Zentralbl. Bakteriol. Orig. 192:133–135 [PubMed] [Google Scholar]
  • 5. Hachem R, et al. 1996. Cutaneous and pulmonary infections caused by Mycobacterium vaccae. Clin. Infect. Dis. 23:173–175 [DOI] [PubMed] [Google Scholar]
  • 6. Hadley EA, et al. 2005. Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis. Clin. Exp. Immunol. 140:101–108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Hrouda D, Baban B, Dunsmuir WD, Kirby RS, Dalgleish AG. 1998. Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172). Br. J. Urol. 82:568–573 [DOI] [PubMed] [Google Scholar]
  • 8. Otto TD, Sanders M, Berriman M, Newbold C. 2010. Iterative Correction of Reference Nucleotides (iCORN) using second generation sequencing technology. Bioinformatics 26:1704–1707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Shirtcliffe PM, Goldkorn A, Weatherall M, Tan PL, Beasley R. 2003. Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma. Respirology 8:497–503 [DOI] [PubMed] [Google Scholar]
  • 10. Stanford J, Stanford C, Grange J. 2004. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. Front. Biosci. 9:1701–1719 [DOI] [PubMed] [Google Scholar]
  • 11. Swain MT, et al. 2012. A post-assembly genome-improvement toolkit (PAGIT) to obtain annotated genomes from contigs. Nat. Protoc. 7:1260–1284 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Tsai IJ, Otto TD, Berriman M. 2010. Improving draft assemblies by iterative mapping and assembly of short reads to eliminate gaps. Genome Biol. 11:R41 doi:10.1186/gb-2010-11-4-r41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Wayne LG, Kubica GP. 1986. The mycobacteria, p 1435–1457. In Holt JG, Sneath PH, Mair NS, Sharpe ME. (ed), Bergey's manual of systematic bacteriology, vol 2 Williams & Wilkins, Baltimore, MD [Google Scholar]
  • 14. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18:821–829 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES